An iridoid glycoside with diverse biological activities reduces microvessel formation by 67 in a chick embryo chorioallantoic membrane assay at 2 g/egg inhibits LPS-induced increases in TNF-a IL-1B and IL-6 production in RAW 264.7 macrophages in a concentration-dependent manner at 20 40 and 80 mg/L reduces lung MPO activity and BALF levels of TNF-a IL-1B and IL-6 in a mouse model of LPS-induced acute lung injury at 20 40 and 80 mg/kg dietary administration decreases body weight gain WAT weight and the ratio of WAT weight to body weight in a high-fat diet-induced mouse model of metabolic syndrome